Cancer Statistics, 2016
Cancer Statistics, 2016
复制标题
DOI：
10.3322/caac.21332
复制
发表时间：
2016-01-01
影响因子：
254.7
通讯作者：
Jemal, Ahmedin
中科院分区：
文献类型：
--
作者：
Siegel, Rebecca L.;Miller, Kimberly D.;Jemal, Ahmedin
每年，美国癌症协会都会估计当年美国新发癌症病例和死亡人数，并汇编有关癌症发病率、死亡率和生存率的最新数据。发病率数据由国家癌症研究所（监测、流行病学和最终结果[SEER]计划）、疾病控制和预防中心（国家癌症登记计划）和北美中央癌症登记协会收集。死亡率数据由国家卫生统计中心收集。2016年，预计美国将发生1，685，210例新发癌症病例和595，690例癌症死亡。总体癌症发病率趋势（13个最古老的SEER登记）在女性中是稳定的，但在男性中每年下降3.1%（从2009年到2012年），其中大部分是因为最近前列腺癌诊断的快速下降。自1991年以来，癌症死亡率下降了23%，到2012年避免了170多万人死亡。尽管取得了这一进展，但肝癌、胰腺癌和子宫体癌的死亡率仍在上升，癌症现在是21个州的主要死亡原因，主要原因是心脏病死亡率大幅下降。在儿童和青少年（出生年龄-19岁）中，脑癌已超过白血病，成为癌症死亡的主要原因，因为白血病的治疗取得了巨大进展。加快抗癌进展需要增加国家对癌症研究的投资，并在所有人口中应用现有的癌症控制知识。(C)2016美国癌症协会
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data were collected by the National Cancer Institute (Surveillance, Epidemiology, and End Results [SEER] Program), the Centers for Disease Control and Prevention (National Program of Cancer Registries), and the North American Association of Central Cancer Registries. Mortality data were collected by the National Center for Health Statistics. In 2016, 1,685,210 new cancer cases and 595,690 cancer deaths are projected to occur in the United States. Overall cancer incidence trends (13 oldest SEER registries) are stable in women, but declining by 3.1% per year in men (from 2009-2012), much of which is because of recent rapid declines in prostate cancer diagnoses. The cancer death rate has dropped by 23% since 1991, translating to more than 1.7 million deaths averted through 2012. Despite this progress, death rates are increasing for cancers of the liver, pancreas, and uterine corpus, and cancer is now the leading cause of death in 21 states, primarily due to exceptionally large reductions in death from heart disease. Among children and adolescents (aged birth-19 years), brain cancer has surpassed leukemia as the leading cause of cancer death because of the dramatic therapeutic advances against leukemia. Accelerating progress against cancer requires both increased national investment in cancer research and the application of existing cancer control knowledge across all segments of the population. (C) 2016 American Cancer Society.